- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/41 - Y being a hydrogen or an acyclic carbon atom
Patent holdings for IPC class C07C 323/41
Total number of patents in this class: 118
10-year publication summary
14
|
11
|
7
|
16
|
8
|
2
|
2
|
15
|
5
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Corteva Agriscience LLC | 2679 |
9 |
Nacuity Pharmaceuticals, Inc. | 41 |
4 |
Boehringer Ingelheim International GmbH | 4750 |
3 |
Board of Regents, The University of Texas System | 5641 |
3 |
Alberta Health Services | 219 |
3 |
The Governing Council of The University of Toronto, | 1434 |
3 |
The Regents of the University of California | 19572 |
2 |
Syngenta Participations AG | 3029 |
2 |
Centre National de La Recherche Scientifique | 10140 |
2 |
Bayer Cropscience AG | 2136 |
2 |
The General Hospital Corporation | 4655 |
2 |
Purdue Research Foundation | 3480 |
2 |
Flexus Biosciences, Inc. | 13 |
2 |
Max-delbruck-centrum fur Molekulare Medizin | 54 |
2 |
Taisho Pharmaceutical Co., Ltd. | 854 |
2 |
Tohoku University | 2689 |
2 |
Toyama Chemical Co., Ltd. | 108 |
2 |
Thiogenesis Therapeutics, Inc. | 10 |
2 |
Koranex Capital | 15 |
2 |
Hong Kong King-friend Industrial Company Ltd. | 33 |
2 |
Other owners | 65 |